Dugald Seely is a naturopathic doctor and clinician scientist whose focus is on the application and evaluation of integrative oncology. Embodying a synthesis of evidence based complementary medicine with conventional medicine, integrative oncology offers a path for improved clinical care that is obvious to the conscientious practitioner and that best supports patients in the way they most need. Dr. Seely seeks to build a richer integration of this medicine within the health care system as a respected path for practitioners and researchers and ultimately for patients to be best served.
Dr. Seely is the founder and executive director of the Ottawa Integrative Cancer Centre (OICC) and executive director for the department of research & clinical epidemiology at the Canadian College of Naturopathic Medicine. Dr. Seely is an affiliate investigator at the Ottawa Hospital Research Institute; Adjunct Professor with the Faculty of Medicine at the University of Ottawa; Integrative Oncology Section Editor for the journal Current Oncology; and Vice President of the Oncology Association of Naturopathic Physicians. In research, Dr. Seely has led numerous clinical studies and synthesis reviews having published over 70 peer-reviewed papers. Seely is a frequent speaker and is actively engaged in the research community through a number of associations. In clinic, Dr. Seely sees patients three days a week at the OICC and is thrilled to be able to combine his passion for research and in the service of the patients he cares for.
Dr. Rogers Prize Lecture – Applying the Right Measure(s) to Integrative Oncology: Using Research to Explore Integrative Cancer Care
Through the lens of research, Dr. Seely will explore the application of integrative medicine and particularly naturopathic oncology at the Ottawa Integrative Cancer Centre as well as at other integrative clinics across North America.
Dr. Seely will use three large studies based on completely different designs to elucidate some of the promise and challenges in applying integrative oncology at the clinic and in hospital. Studies include a multi-centred double blind randomized clinical trial, a collaborative North American prospective observational study, and a pragmatic multi-phase, multi-centre randomized clinical trial. Issues relating to methodology, collaboration, coordination and clinically relevant interventions will be discussed.